The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

7 Jan 2019 14:00

RNS Number : 4077M
Science in Sport PLC
07 January 2019
 

For immediate release

7 January 2019

 

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Issue of equity

 

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, announces that it has applied for 416,667 new ordinary shares of 10 pence each ("New Ordinary Shares") to be admitted to trading on AIM ("Admission").

 

The New Ordinary Shares are being issued as consideration related to sponsorship services. It is expected that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 11 January 2019.

 

Following admission, the Company will have 122,384,470 ordinary shares of 10 pence each ("Ordinary Shares") outstanding, none of which are held in treasury. The figure of 122,384,470 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

For further information:

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

 

Elizabeth Lake, CFO

 

 

 

Liberum Capital Limited - NOMAD and Broker

+44 (0) 20 3100 2227

Clayton Bush

 

Chris Clarke

 

 

 

Instinctif Partners

+44 (0) 20 7457 2020

Matthew Smallwood

 

Tom Berger

 

 

Notes for editors

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products.

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars, hydration tablets and shots; SiS REGO, including protein-based recovery powders; SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance; SiS Supplements, comprising BCAA Perform, Creatine, Beta Alanine and L Glutamine; SiS Athlete Health, vitamins and supplements range designed to support and maintain immune function, digestive health and bone health. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition supplier to professional cycling organisations Team SKY, British Cycling, Cycling Australia, and USA Cycling. SiS is also a partner to British Triathlon and Rock n Roll Marathon Series. Along with supplying over 70 professional English & Scottish League football teams, SiS Sports Nutrition is the partner to the world's most popular football club, Manchester United FC. In addition, Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE are Brand Ambassadors.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

About PhD

PhD is a UK-headquartered premium protein brand. Since being founded by Jason Rickaby and Mark Bowering in 2005, PhD has developed into one of the UK's leading protein brands with a reputation for high quality and innovative products aimed at sports enthusiasts and gym lifestyle consumers.

It has c.24 employees and an experienced management team that has a track record of delivering consistent revenue growth and profitability. For the year ended August 2018, PhD reported revenues of £20.8 million and adjusted EBITDA of £2.8 million.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEXDLFBKFFEBBZ
Date   Source Headline
5th Jan 20227:00 amRNSAppointment of Joint Broker
4th Jan 20224:51 pmRNSHolding(s) in Company
7th Oct 20213:12 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSPartnership with Milwaukee Bucks
15th Sep 20217:00 amRNSInterim Results
9th Sep 20217:00 amRNSInvestor Presentation
2nd Aug 20217:00 amRNSNew PhD Nutrition 'Life' Range
19th Jul 20217:00 amRNSLaunch of new category-leading product range
14th Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20213:44 pmRNSResult of AGM
22nd Jun 20213:10 pmRNSHolding(s) in Company
21st Jun 202110:57 amRNSHolding(s) in Company
20th May 20217:00 amRNSNotice of AGM
19th May 202112:59 pmRNSNotification of Major Holdings
10th May 20215:10 pmRNSPDMR Share Purchases
10th May 20217:00 amRNSExtends Partnership with INEOS Grenadiers
28th Apr 202111:01 amRNSPDMR Share Purchases
18th Mar 20212:34 pmRNSNotification of Major Holdings
17th Mar 20217:00 amRNSFinal Results
11th Mar 20217:00 amRNSInvestor Presentation
5th Feb 202112:50 pmRNSNotification of Major Holdings
1st Feb 20211:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSCapital Markets Day
15th Jan 20212:06 pmRNSSecond Price Monitoring Extn
15th Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSPre-Close Trading Update
4th Jan 20217:00 amRNSDates for Investor Presentation and Trading Update
4th Dec 20208:52 amRNSNotification of Major Holdings
3rd Dec 202012:16 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSTrading Update
19th Nov 20207:00 amRNSIntroduction of Recyclable Packaging Range
17th Nov 202011:52 amRNSNotification of Major Holdings
3rd Nov 20204:17 pmRNSHolding(s) in Company
5th Oct 20207:00 amRNSPDMR Share Purchases
1st Oct 20207:00 amRNSGrant of Options
21st Sep 20202:05 pmRNSSecond Price Monitoring Extn
21st Sep 20202:00 pmRNSPrice Monitoring Extension
21st Sep 202011:06 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
21st Sep 20209:05 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
16th Sep 20207:00 amRNSInterim Results
10th Sep 20204:39 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSInvestor Presentation
9th Jul 20207:00 amRNSHalf Year Trading Update
30th Jun 20203:32 pmRNSNotification of Major Holdings
25th Jun 20205:03 pmRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.